Log In Sign up
The largest database of trusted experimental protocols
> Disorders > Disease or Syndrome > Hyponatremia

Hyponatremia

Hyponatremia is a electrolyte disorder characterized by an abnormally low concentration of sodium in the blood, typically below 135 mmol/L.
This can lead to a range of symptoms, including headache, nausea, fatigue, and confusion.
Hyponatremia can be caused by a variety of factors, such as excessive fluid intake, adrenal insufficiency, or certain medications.
Proper diagnosis and treatment of hyponatremia is essential to prevent potentially serious complications.
Researchers studying this condition can leverage the PubCompare.ai platform to optimize their research protocols, ensuring reproducibility and accuracy in their hyponatremia studies.

Most cited protocols related to «Hyponatremia»

1
Predicting Waitlist Mortality for Liver Transplant
Data on all patients who were registered on the waiting list in the United States were obtained from the OPTN. These data were available from the Standard Transplant Analysis and Research file as of May 1, 2007. The predictor variables in this analysis consisted of the MELD score and the serum sodium concentration at the time of registration on the waiting list. The data file also included the outcome of waiting (i.e., transplantation, death, or withdrawal from the list for other reasons), which was used to define the outcome variable in the analysis — namely, death before transplantation and within 90 days after registration.
Since our data spanned 2 calendar years, we adopted a strategy to build a prediction model based on data from 2005 and to validate the model using the 2006 data. Since we planned to assign a prognostic score based on the MELD score and the serum sodium concentration to the current and future registrants on the waiting list, it was important that a model derived from one calendar year remain valid when it was applied to another year. Our target population was all adults with cirrhotic liver disease in the United States who were listed for a first liver transplantation. Therefore, among all registrants on the waiting list, we excluded those who were younger than 18 years of age, those with liver disease other than cirrhosis (e.g., acute liver failure or hepatocellular carcinoma), and those listed for repeat liver transplantation, as well as patients for whom complete laboratory data were not available within 5 days after they had been placed on the waiting list. In addition, since we were interested in the effects of hyponatremia, a small proportion of patients with hypernatremia (se- rum sodium concentration >150 mmol per liter) (24 of 6793 patients, or 0.4%) were excluded from the model development. However, patients with hypernatremia were included in the model validation in order to ensure that the new score could be applied globally. In candidates listed at more than one center concurrently, we identified the first date of registration on the waiting list, using a de-identified unique candidate code.
Kim W.R., Biggins S.W., Kremers W.K., Wiesner R.H., Kamath P.S., Benson J.T., Edwards E, & Therneau T.M. (2008). Hyponatremia and Mortality among Patients on the Liver-Transplant Waiting List. The New England journal of medicine, 359(10), 1018-1026.
Publication 2008
Adult Hepatocellular Carcinomas Hypernatremia Hyponatremia Liver Cirrhosis Liver Diseases Liver Failure, Acute Liver Transplantations Patients Serum Sodium Target Population Transplantation Youth
2
Identifying Clinically Confirmed ESLD
We determined the PPVs of three ICD-9-CM-based coding algorithms to identify clinically confirmed ESLD (Table 1). Our focus was on PPV because if this parameter is sufficiently high, we and other researchers will have confidence that the algorithm identified ESLD with minimal misclassification. Algorithm 1 required a diagnosis of a hepatic decompensation event plus a chronic liver disease diagnosis. Algorithm 2 required a diagnosis of a hepatic decompensation event plus a cirrhosis diagnosis. Algorithm 3 required a diagnosis of a hepatic decompensation event, chronic liver disease, and cirrhosis. The rationale for these algorithms was based on observations that some patients with ESLD may only be coded for a chronic liver disease and not cirrhosis, or vice versa. The large sample size of algorithm 3 permitted determination of a variety of PPVs using different cut-off points for the minimum number of hepatic decompensation codes. Finally, to estimate the likelihood of missing ESLD events with the specified algorithms, we evaluated for the presence of ESLD in a sample of patients who did not meet the algorithms but who had non-specific diagnoses that typically accompany ESLD (e.g. coagulopathy, jaundice, hyponatremia, and portal hypertension).
All data were analyzed using State 12.0 (Stata Corp, College Station, TX, USA).
Goldberg D., Lewis J., Halpern S., Weiner M, & Lo Re V I.I.I. (2012). Validation of a coding algorithm to identify patients with end-stage liver disease in an administrative database. Pharmacoepidemiology and drug safety, 21(7), 765-769.
Publication 2012
Blood Coagulation Disorders Cirrhosis Diagnosis Disease, Chronic Hyponatremia Icterus Liver Liver Diseases Patients Portal Hypertension
3
Comprehensive Cirrhosis Case Identification

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2019
Abdomen Alcoholic Liver Diseases Alcoholics Alcohol induced encephalopathy Arteries Ascites Cholangitis Chronic Liver Failure Cirrhosis Cirrhosis, Biliary Diagnosis Encephalopathies Endoscopy Esophageal and Gastric Varices Esophageal Varices Fibrosis Fibrosis, Liver Gastric Varix Gastrointestinal Hemorrhage Genetic Linkage Analysis Hepatectomy Hepatic Insufficiency Hepatitis, Alcoholic Hepatocellular Carcinomas Hepatorenal Syndrome Hospitalization Hyponatremia Icterus Liver Liver Cirrhosis Liver Cirrhosis, Alcoholic Paracentesis Patients Peritonitis Portal Hypertension Primary Biliary Cholangitis Radiofrequency Ablation Rectum Sclerosis Secondary Biliary Cholangitis Shunt, Transjugular Intrahepatic Portosystemic Varices
4
Hyponatremia and Hiccups: A Case-Control Study
The data used in this paper is from a case control study on hyponatremia and hiccups conducted in Christian Medical College, Vellore, Tamil Nadu, India.[8 (link)] The main aim of the hyponatremia study was to find an association between hyponatremia and hiccups after adjusting for potential confounding factors such as gender, age, renal disease, and creatine level in hospitalized patients. The dataset consists of 50 subjects with hiccups (cases) and 50 subjects without hiccups (controls). The hiccups groups were subdivided according to the severity of the disease so that among 50 subjects with hiccups, 23 subjects had mild hiccups, 12 subjects had moderate hiccups, and 15 subjects had a severe kind of hiccups. For an illustrative purpose, we have chosen 23 mild hiccup cases and 50 controls from the dataset and other confounding factors were randomly generated based on the given estimated values. Data were analyzed using SAS 9.2 for windows (SAS Institute, Inc., Cary, NC, 2000) software.[9 ]
Devika S., Jeyaseelan L, & Sebastian G. (2016). Analysis of sparse data in logistic regression in medical research: A newer approach. Journal of Postgraduate Medicine, 62(1), 26-31.
Publication 2016
Creatine Hyponatremia Kidney Diseases Patients
5
Optimized Stroop App for Cognitive Assessment

Protocol full text hidden due to copyright restrictions

Open the protocol to access the free full text link

Publication 2014
Hyponatremia Liver Cirrhosis Touch Perception

Most recents protocols related to «Hyponatremia»

1
Characterization of Primary Adrenal Insufficiency
We studied 94 consecutive patients with PAI who presented to our hospital between 2006 and 2019 (Fig. 1). The hospital is a state government-funded referral center. Five patients, whose information was not available in the case records, were excluded, and the data of 89 patients were analyzed in this report. Of these, 72 patients were studied retrospectively from their records and 17 patients (October 2017 onward) were prospectively enrolled. The patients had an age ≥15 years at enrollment (mean ± s.d., 47 ±15 years; range, 15–83 years). All patients were prospectively followed, with their last visit or telephonic contact in January–May 2022 (median (range) 5.9 years (0.1–15.7 years)).

Recruitment and investigations in patients with primary adrenal insufficiency.

The diagnosis of PAI was suspected clinically (weight loss, fatigue, nausea, vomiting, diarrhea, hyperpigmentation, hyponatremia and hyperkalemia) and confirmed by measuring serum cortisol at 8:00 to 9:00 h and 1 h after intramuscular stimulation with 250 µg synthetic 1-24 adrenocorticotropic hormone (ACTH) (Synacthen®, Ciba Geigy, Basel, Switzerland). A value <500 nmol/L was diagnostic of cortisol deficiency. In 25 (28%) patients, the diagnosis was made on the basis of plasma cortisol <140 nmol/L alone at the time of acute stress at presentation, and 14 of 25 cases had undetectable cortisol (<27 nmol/L). Plasma ACTH (normal range 2.2–13.3 pmol/L) was elevated (15–1085 pmol/L) in 72 of 78 patients in whom it was tested. In the remaining six patients, ACTH had been collected without stopping glucocorticoid treatment. Data on 29 patients with AH with a shorter follow-up have been reported earlier (10 (link)). All patients gave written informed consent, and the study was approved by the 105th Institutional Ethics Committee meeting of Sanjay Gandhi Postgraduate Institute of Medical Sciences (IEC code 2018-119 IMP-105).
All patients had a detailed clinical evaluation at presentation. Acute adrenal crisis was diagnosed by the presence of hypotension responsive to intravenous hydrocortisone and saline infusion (2 (link)). Evidence of infection with tuberculosis (current or past history of extra-AT and prescription of treatment with anti-tuberculous drugs) or Histoplasma (history of exposure to birds, cave exploration and farming occupation) was sought. Clinical and biochemical evidence of other organ-specific autoimmune disorders were assessed.
All patients underwent an abdominal computerized tomography (CT) with contrast (n = 84) or ultrasonography (n = 2) to visualize the adrenal glands (Fig. 1). Abdominal imaging was not performed in three patients (one each with Allgrove’s syndrome and autoimmune polyglandular syndrome type 1 and 2). Adrenal biopsy (n = 50) or fine needle aspiration (FNA) (n = 10) was performed in 60 patients with enlarged adrenal glands. It was not successful due to poor access in four patients and not attempted in a patient with anti-phospholipid syndrome. All tissue samples were processed to detect Mycobacterium tuberculosis using Ziehl–Neelsen stain and cultured on Lowenstein Jensen medium. Genetic testing for M tuberculosis (Xpert MTB,RIF, Cepheid, Sunnyvale, CA, USA) was available for three patients. All samples were also stained for Histoplasma using periodic acid Schiff and Gomori–Grocott silver stain. For culture of Histoplasma, specimens were incubated for 4–6 weeks using Sabouraud dextrose agar medium followed by transfer into phase conversion medium. Testing for Histoplasma antigen is not available in India.
Gunna S., Singh M., Pandey R., Marak R.S., Aggarwal A., Mohanta B., Yu L, & Bhatia E. (2023). Etiology, clinical characteristics and mortality among Indian patients with Addison’s disease. Endocrine Connections, 12(3), e220439.
Publication 2023
Abdomen Addison Disease Adrenal Glands Agar Antigens Antiphospholipid Syndrome Aspiration Biopsy, Fine-Needle Autoimmune Diseases Aves Biopsy Corticotropin Diarrhea Fatigue Glucocorticoids Glucose Histoplasma Hydrocortisone Hyperpigmentation Hyponatremia Infection Institutional Ethics Committees Mycobacterium tuberculosis Nausea Patients Periodic Acid Pharmaceutical Preparations Plasma Polyglandular Type I Autoimmune Syndrome Saline Solution Serum Silver Stains Tissues Triple-A Syndrome Tuberculosis Ultrasonography X-Ray Computed Tomography
2
Predicting Early Prognosis in Acute Guillain-Barré Syndrome
A retrospective design was used to study patients with confirmed acute GBS who were admitted to the Department of Neurology at the Beijing Tongren Hospital of Capital Medical University from 2007 to 2021. (1) Inclusion criteria: (i) met the diagnostic criteria of the 2019 Chinese Guillain-Barré Syndrome Diagnosis and Treatment Guidelines developed by the Chinese Medical Association [3 ]; (ii) first-onset admission. (2) Exclusion criteria: (i) patients with combined definite intracranial lesions; (ii) patients with chronic inflammatory demyelinating polyradiculoneuropathy (CIDP); (iii) patients who could not be excluded from peripheral neuropathy caused by other etiologies; (iv) patients with incomplete case data.
Measured characteristics included gender, age at onset, antecedent infection (whether diarrhea, upper respiratory tract infection, pulmonary infection, or other unexplained infection occurred within 4 weeks prior to onset), cranial nerve involvement (presence of ophthalmoplegia, facial palsy, dysarthria, dysphagia, weak neck, and shoulder rotation), presence of pulmonary infection (symptoms such as cough, sputum, and fever during the course of the disease, and confirmation with high-resolution computed tomography (HRCT) of the lungs). Mechanical ventilatory support, hyponatremia, hypoalbuminemia, impaired fasting glucose and the peripheral blood neutrophil-to-lymphocyte ratio (NLR) were analyzed as alternative influencing factors. Peripheral blood was collected from all patients within 24 h of admission. Plasma sodium < 135 mmol/L was considered as combined hyponatremia. Fasting plasma glucose (FPG) > 6.1 mmol/L was considered impaired fasting glucose. Plasma albumin < 35 g/L was defined as hypoalbuminemia. An elevated NLR was defined as an NLR value > 2.135.
The GBS disability score developed by Hughes (Hughes functional grading scale, HFGS) [4 (link)] et al. was used for assessment on the day of discharge: 0 represented a completely normal state; 1 represented mild signs or symptoms and ability to run; 2 represented the ability to walk ≥ 10 m alone but the inability to run; 3 represented the ability to walk 10 m in open space with assistance; 4 represented a bedridden or wheelchair bound state; 5 represented a requirement of assisted ventilatory support; and 6 referred to death. Those with GBS disability scores > 3 at discharge were considered to have a poor early prognosis and those with GBS scores ≤ 3 had better early prognoses.
SPSS 23.0 and MedCalc statistical software were used for the analysis. The χ2 test or Fisher's exact test was used to compare groups of count data. (1) Univariate analysis was used to derive risk factors for poorer early prognosis (HFGS score > 3) in patients with GBS. (2) Statistically significant (P < 0.05) influencing factors obtained from this analysis were then included in a multivariate logistic regression analysis, and regression coefficients were calculated. (3) The integer value closest to the regression coefficient was used as the influencing factor score value in order to establish an early prognostic scoring system. (4) The predictive value of the scoring system was evaluated by plotting the receiver operating curve (ROC) curve: the area under the ROC curve (AUC) was calculated, the appropriate cut-off value was selected, and the sensitivity, specificity, positive predictive value, and negative predictive value were calculated.
Di X., Wang J., Li L, & Liu L. (2023). Establishment of a single-center-based early prognostic scoring system for Guillain-Barré syndrome. BMC Neurology, 23, 97.
Full text: Click here
Publication 2023
BLOOD Chinese Cough Cranial Nerves Debility Deglutition Disorders Diagnosis Diarrhea Disabled Persons Disease Progression Dysarthria Fever Gender Glucose Guillain-Barre Syndrome Hypersensitivity Hypoalbuminemia Hyponatremia Infection Lung Lymphocyte Neck Neutrophil Ophthalmoplegia Paralysis, Facial Patient Discharge Patients Peripheral Nervous System Diseases Plasma Plasma Albumin Polyradiculoneuropathy, Chronic Inflammatory Demyelinating Prognosis Shoulder Sodium Sputum Upper Respiratory Infections Wheelchair X-Ray Computed Tomography
3
Diagnosis and Monitoring of Delayed Cerebral Ischemia
All patients underwent angiography to diagnose the ruptured aneurysm; patients with a negative angiogram were excluded from the present study. The remaining patients were screened for DIC by computed tomography, and the screening was finally confirmed by MRI. Computed tomography or magnetic resonance imaging was performed postoperatively 24 to 48 h before discharge. In addition, CT perfusion (CTP) or transcranial Doppler (TCD) may also be used.
Delayed cerebral ischemia (DCI) was defined as the development of new focal neurological deficits or a decrease in ≥2 points on the Glasgow Coma Scale score for a duration ≥1 h in conscious patients, with the exclusion of any other explanation for the deterioration, such as infection with an associated decrease in consciousness level, rebleeding, edema (increasing) hydrocephalus, hypoglycemia or hyponatremia or hypotension, or any other possible cause for deterioration as judged by the treating physician (Vergouwen et al., 2010 (link); Fan et al., 2021 (link)). Alternatively, new ischemic lesions were found by CT and/or MRI, or perfusion decreased in the corresponding brain functional area showed by CTP, and/or blood flow velocity increased in the corresponding brain area showed by TCD.
Wang J., Li R., Li S., Ma T., Zhang X., Ren Y., Chen X, & Peng Y. (2023). Intraoperative arterial pressure and delayed cerebral ischemia in patients with aneurysmal subarachnoid hemorrhage after surgical clipping: A retrospective cohort study. Frontiers in Neuroscience, 17, 1064987.
Full text: Click here
Publication 2023
Aneurysm, Ruptured Angiography Blood Flow Velocity Brain Cerebral Ischemia Consciousness Diagnosis Edema Hydrocephalus Hypoglycemia Hyponatremia Infection Patient Discharge Patients Perfusion Physicians Ultrasonography, Doppler, Transcranial X-Ray Computed Tomography
4
Fluid Management in COVID-19 Acute Lung Injury
We reviewed data from medical records: demographic; clinical, laboratory; blood gas; chest tomography (CT); the oxygen therapy support; and mechanical ventilation (IMV) requirements, all of which were reviewed and recorded by investigators. Clinical outcomes were followed up to 1 May 2022.
In this case–control study, we compared fluid management applied during eight days in patients with acute lung injury for COVID-19: a conservative strategy for the control group, and NEGBAL approach for the NEGBAL group.
The control group received standard treatment. It was based on dexamethasone 6 mg/day, enoxaparin 40 mg/day, oxygen supplement (nasal cannula, reservoir mask, HFNC), invasive or non-invasive mechanical ventilation and standard care.
The NEGBAL group underwent, in addition to the standard care, a treatment with furosemide in continuous intravenous infusion: the NEGBAL approach.
Inclusion criteria were as follows: (1) age older than 18 years; (2) confirmed diagnosis of COVID-19 through real-time reverse transcriptase polymerase chain reaction (RT-PCR) assay with samples obtained from nasopharyngeal swab or positive antinucleocapsid IgM antibodies; (3) PaO2/FiO2 (ratio of arterial oxygen partial pressure to fractional inspired oxygen) < 300; and (4) tomographic evidence of acute pulmonary edema, defined as ground glass infiltration, dilated superior vena cava, large pulmonary arteries, and dilated right ventricle or dilated cardiac axis.
Exclusion criteria were as follows: (1) patients with indication for diuretics for another reason; (2) renal failure; (3) cardiac failure; (4) hepatic failure; (5) hypernatremia or hyponatremia; (6) hypotension, use of inotropics or shock; (7) receiving antivirals or monoclonal antibodies.
CTs were performed upon admission to ICU, CT controls were scheduled for day 4 (+/− 1 day), day 8 (+/− 1 day), and day 12 (+/− 1 day). A 1.5 mm slice thickness and 1.5 mm interval were used for the axial image.
For the evaluation of CT infiltrates, the scoring was as described by Pan F et al. [66 (link)]. The measurement of the superior vena cava diameter (Ø svc) in the CT was performed just above the arch of the azygos veins.
Santos J.L., Zanardi P., Alo V., Dos Santos V., Bovone L., Rodriguez M., Magdaleno F., De Langhe V., Villoldo A., Martinez Souvielle R., Alconcher J., Quiros D., Milicchio C, & Garcia Saiz E. (2023). Lung Injury in COVID-19 Has Pulmonary Edema as an Important Component and Treatment with Furosemide and Negative Fluid Balance (NEGBAL) Decreases Mortality. Journal of Clinical Medicine, 12(4), 1542.
Full text: Click here
Publication 2023
Acute Lung Injury Antiviral Agents Arteries Biological Assay BLOOD Chest Clinical Laboratory Services COVID 19 Dexamethasone Diagnosis Dietary Supplements Diuretics Enoxaparin Epistropheus Furosemide Heart Heart Failure Hepatic Insufficiency Hypernatremia Hyponatremia Immunoglobulin M Intravenous Infusion Kidney Failure Mechanical Ventilation Monoclonal Antibodies Nasal Cannula Nasopharynx Noninvasive Ventilation Oxygen Partial Pressure Patients Pulmonary Artery Pulmonary Edema Real-Time Polymerase Chain Reaction Reverse Transcriptase Polymerase Chain Reaction RNA-Directed DNA Polymerase Shock Therapies, Oxygen Inhalation Tomography Veins, Azygos Vena Cavas, Superior Ventricles, Right
5
Retrospective Analysis of Pancreatic Cancer Resection
This clinical retrospective study included 148 consecutive patients who underwent surgical resection for PDAC from March 2008 to December 2020, in our department, without neoadjuvant treatment. Routinely, a laparotomic cephalic pancreaticoduodenectomy (CPD) without pyloric preservation was the technique used for tumors with a cephalic location. Clinicopathological data were obtained by reviewing the patients’ clinical histories, using the hospital database records. The study was approved by our hospital’s Ethics Committee [21 (link)].
For preoperative analytical parameters, hyponatremia was considered when sodium <135 mEq/L, increased aspartate aminotransferase (AST) ≥35 U/L, increased alanine aminotransferase (ALT) ≥45 U/L, increased alkaline phosphatase (AP) >120 U/L, increased gamma-glutamyltransferase (GGT) ≥55 U/L and hypoalbuminemia when albumin <3.5 g/dL. For carbohydrate antigen (CA) 19.9 and carcinoembryonic antigen (CEA), cutoff values of 500 U/mL [22 (link)] and 5 ng/mL [23 (link)] were defined, respectively. Jaundice was considered for a total bilirubin (BR) value greater than 2.5 mg/dL [24 (link)]. Postoperative complications were defined as those occurring in the first 30 days after surgery and classified according to the Clavien–Dindo classification [25 (link)]. Delayed gastric emptying (DGE) [26 (link)] and postoperative pancreatic fistula (POPF) [27 (link)] were defined according to the International Study Group of Pancreatic Surgery. R1 resections were defined as those with a tumor-free margin ≤1 mm.
Lymph node (LN) ratio was calculated by dividing the number of invaded LNs by the number of resected LNs. The TSA was calculated for 78 patients. For each patient, 3 representative histological areas of the surgical specimen were selected by an expert pathologist and photographed with a total magnification of 20×. Image collection and analysis were blinded to the outcome. Hematoxylin and eosin-stained slides were observed using a light microscope (Nikon Eclipse 50i) and images were obtained using a Nikon Digital Slight DS-Fi1 camera. Subsequently, using the software [28 (link),29 (link)] QuPath-0.2.3, the stromal area was delimited and calculated to then determine the mean of the 3 areas. Several cutoff values were tested for the study of the TSA. The DFS was calculated from the date of surgery to the date of relapse and the OS from the date of surgery to the date of death or of data analysis.
Amaral M.J., Amaral M., Freitas J., Oliveira R.C., Serôdio M., Cipriano M.A, & Tralhão J.G. (2023). Tumor Stroma Area and Other Prognostic Factors in Pancreatic Ductal Adenocarcinoma Patients Submitted to Surgery. Diagnostics, 13(4), 655.
Full text: Click here
Publication 2023
Albumins Alkaline Phosphatase Anophthalmia with pulmonary hypoplasia Bilirubin Biologic Preservation CA-19-9 Antigen CEACAM5 protein, human D-Alanine Transaminase Eosin Ethics Committees, Clinical gamma-Glutamyl Transpeptidase Hematoxylin Hypoalbuminemia Hyponatremia Icterus Laparotomy Light Microscopy Lymphatic Vessel Tumors Neoadjuvant Therapy Neoplasms Operative Surgical Procedures Pancreas Pancreatic Fistula Pancreaticoduodenectomy Pathologists Patients Postoperative Complications Pylorus Relapse Sodium Transaminase, Serum Glutamic-Oxaloacetic

Top products related to «Hyponatremia»

1
Spss statistical software by IBM
Sourced in United States, Japan, United Kingdom, Belgium, Austria, Australia, Spain
SPSS is a comprehensive statistical software package that enables data analysis, data management, and data visualization. It provides a wide range of statistical techniques, including descriptive statistics, bivariate analysis, predictive analytics, and advanced modeling. SPSS is designed to help users efficiently manage and analyze large datasets, making it a valuable tool for researchers, statisticians, and data analysts.
2
Spss for windows version 22 by IBM
Sourced in United States, Japan, United Kingdom
SPSS for Windows version 22.0 is a statistical software package designed to analyze and manage data. It provides a range of tools for data manipulation, statistical analysis, and visualization. The software is compatible with the Windows operating system.
3
Sas version 9 by SAS Institute
Sourced in United States, Austria, Japan, Cameroon, Germany, United Kingdom, Canada, Belgium, Israel, Denmark, Australia, New Caledonia, France, Argentina, Sweden, Ireland, India
SAS version 9.4 is a statistical software package. It provides tools for data management, analysis, and reporting. The software is designed to help users extract insights from data and make informed decisions.
4
Spss software by IBM
Sourced in United States, Japan, United Kingdom, Germany, Austria, Belgium, China, Italy, India, Israel, France, Spain, Denmark, Canada, Hong Kong, Poland, Australia
SPSS is a software package used for statistical analysis. It provides a graphical user interface for data manipulation, statistical analysis, and visualization. SPSS offers a wide range of statistical techniques, including regression analysis, factor analysis, and time series analysis.
5
Stata v 12 by StataCorp
Sourced in United States, United Kingdom, Denmark
Stata V.12 is a software package designed for statistical analysis, data management, and graphics. It provides a comprehensive set of tools for researchers, analysts, and professionals in various fields. The core function of Stata V.12 is to facilitate the analysis of data, including the ability to perform a wide range of statistical tests, create graphs and visualizations, and manage complex datasets.
6
Stata version 14 by StataCorp
Sourced in United States, Denmark, Austria, United Kingdom, Japan, Canada
Stata version 14 is a software package for data analysis, statistical modeling, and graphics. It provides a comprehensive set of tools for data management, analysis, and reporting. Stata version 14 includes a wide range of statistical techniques, including linear regression, logistic regression, time series analysis, and more. The software is designed to be user-friendly and offers a variety of data visualization options.
7
Cobas integra 800 by Roche
Sourced in Switzerland, Germany, United States, Japan
The Cobas Integra 800 is a fully automated, high-throughput clinical chemistry analyzer designed for use in medical laboratories. It is capable of performing a wide range of clinical chemistry tests on a variety of sample types. The Cobas Integra 800 utilizes advanced technology to provide accurate and reliable results, with the ability to handle a high volume of samples efficiently.
8
Spss version by IBM
Sourced in United States, United Kingdom, Japan, Germany
SPSS is a software package used for statistical analysis. It provides a graphical user interface and a robust set of tools for data manipulation, analysis, and visualization. SPSS is designed to handle a wide range of data types and supports a variety of statistical techniques, including regression analysis, factor analysis, and time series analysis.
9
Furosemide by Pfizer
Sourced in United States
Furosemide is a diuretic medication used to treat fluid retention and high blood pressure. It works by increasing the amount of water and salt expelled from the body through urine.
10
Ain 76 by Bio-Serv
Sourced in United States
The AIN-76 is a laboratory equipment product designed for research and analysis purposes. It serves as a core component for various scientific applications. The detailed specifications and functionality of the AIN-76 are not available in this response, as providing an unbiased and factual description while maintaining conciseness is not possible.

More about "Hyponatremia"

Hyponatremia, also known as low sodium blood levels or electrolyte imbalance, is a medical condition characterized by an abnormally low concentration of sodium in the bloodstream, typically below 135 mmol/L.
This can lead to a range of symptoms, including headache, nausea, fatigue, confusion, and in severe cases, seizures, coma, and even death.
The causes of hyponatremia can be diverse, such as excessive fluid intake, certain medications (e.g., diuretics like Furosemide), adrenal insufficiency, and underlying medical conditions.
Accurate diagnosis and proper treatment of hyponatremia are crucial to prevent potentially serious complications.
Researchers studying this condition can leverage advanced statistical software like SPSS (Statistical Package for the Social Sciences), SAS (Statistical Analysis System), and Stata to analyze data and optimize their research protocols.
These tools can help ensure reproducibility, accuracy, and efficiency in hyponatremia studies.
For example, SPSS version 22.0 for Windows or Stata version 14 can be used to perform comprehensive statistical analyses, such as descriptive statistics, regression models, and hypothesis testing, which are essential for understanding the complex factors contributing to hyponatremia.
Additionally, laboratory equipment like the Cobas Integra 800 can be used to accurately measure sodium levels in the blood, providing valuable data for hyponatremia research.
By leveraging these resources and the PubCompare.ai platform, researchers can optimize their hyponatremia research protocols, ensuring they follow the best practices and find the most effective approaches for their studies.
This can lead to improved understanding of the condition, better patient outcomes, and advancements in the field of electrolyte disorders.